Serotype replacement after pneumococcal vaccination - Authors' reply

The Lancet

Volumn 379, Issue 9824, 2012, Pages 1388-1389

  Weinberger, Daniel M ^a,c   Malley, Richard ^b   Lipsitch, Marc ^a  

^a Department of Immunology and Infectious Diseases ^*  (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

STREPTOCOCCUS VACCINE; PNEUMOCOCCUS VACCINE;

FOLLOW UP; LETTER; MENINGITIS; PNEUMONIA; PRIORITY JOURNAL; SEROTYPE; VACCINATION; CLASSIFICATION; HUMAN; IMMUNOLOGY; NOTE; PNEUMOCOCCAL INFECTION; SEROTYPING; STREPTOCOCCUS PNEUMONIAE;

HUMANS; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; SEROTYPING; STREPTOCOCCUS PNEUMONIAE;

EID: 84859611364     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(12)60591-1     Document Type: Letter

References (4)

1. D Weinberger, Z Harboe, S Flasche et al. Prediction of serotypes causing invasive pneumococcal disease in unvaccinated and vaccinated populations Epidemiology 22 2011 199 207
2. DF Vestrheim, EA Høiby, MR Bergsaker et al. Indirect effect of conjugate pneumococcal vaccination in a 2 + 1 dose schedule Vaccine 28 2010 2214 2221
3. DF Vestrheim, M Steinbakk, IS Aaberge et al. Post-vaccination increase of serotype 19A pneumococcal disease in Norway is driven by expansion of penicillin-susceptible strains of the ST199 complex Clin Vaccine Immunol 19 2012 443 445
4. JB Rosen, AR Thomas, CA Lexau et al. Geographic variation in invasive pneumococcal disease following pneumococcal conjugate vaccine introduction in the United States Clin Infect Dis 53 2011 137 143